新辅助化疗联合肿瘤细胞减灭术及术后腹腔热灌注化疗治疗晚期卵巢癌的疗效观察

  目的   探讨新辅助化疗联合肿瘤细胞减灭术及术后腹腔热灌注治疗晚期卵巢癌的临床疗效。   方法   分析郑州人民医院从2009年4月至2012年7月收治的60例晚期卵巢癌的患者，分为两组，研究组患者术前采取新辅助化疗联合肿瘤细胞减灭术及术后腹腔热灌注辅助化疗2次（顺铂80 mg），术后给予TC/TP方案化疗，对照组采取常规肿瘤细胞减灭术+术后TC/TP方案化疗，比较两组患者在手术时间、出血量、腹水量、术后化疗疗程、疗效、复发与死亡、生存率等数据的差异。   结果   研究组患者在术中的各项疗效指标优于对照组，且有统计学显著性差异（P < 0.05），临床治疗有效率高于对照组。   结论   在临床上对于晚期卵巢癌患者采取术前新辅助化疗联合肿瘤细胞减灭术术后腹腔热灌注辅助化疗，对于患者的疗效较常规的方法有较大的提高，值得在临床上进行推广。 

Clinical efficacy of neoadjuvant chemotherapy combined with cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP) after operation in advanced ovarian cancer

  Objective   We aimed to investigate the clinical efficacy of neoadjuvant chemotherapy combined with cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP) after the operation of patients with advanced ovarian cancer.   Methods   Analysis of 60 patients with advanced ovarian cancer was performed at the Zhengzhou People's Hospital from April 2009 to July 2012. The patients were divided into two groups, namely, the research and control groups. The research group was treated with neoadjuvant chemotherapy combined with cytoreductive surgery and IHCP twice (cisplatin at 80 mg), and subsequently, with chemotherapy (TC/TP). The control group underwent primary cytoreductive surgery and chemotherapy (TC/TP). We compared the differences between the two groups in terms of the following parameters: operation time, bleeding volume, volume of ascites, and postoperative chemotherapy.   Results   The treatments in the research group were more efficient than those performed on the control group in terms of all the intraoperative indicators, and the difference between the two groups was statistically significant (P < 0.05).   Conclusion   Compared with conventional methods, the neoadjuvant chemotherapy combined with cytoreductive surgery and IHCP after operation was more effective for patients with advanced ovarian cancer. Thus, neoadjuvant chemotherapy combined with cytoreductive surgery and IHCP after operation can be applied in clinical settings.